Global Cell/Tissue Culture Supplies Industry

NEW YORK, Feb. 2, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Cell/Tissue Culture Supplies Industry

http://www.reportlinker.com/p098415/Global-Cell/Tissue-Culture-Supplies-Industry.html

This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in US$ Million by the following Product Segments: Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 131 companies including many key and niche players such as Affymetrix, Inc., AMRESCO, Inc., BD Biosciences, Cell Culture Technologies, LLC, Cell Essentials, Inc., Irvine Scientific, Life Technologies Corporation, Lonza Biologics Plc, Mediatech, Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, SAFC Biosciences, and Vitrolife AB. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CELL/TISSUE CULTURE SUPPLIES MCP-3538

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 2

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

Cell/Tissue Culture Media, Sera and Reagents 3

2. MARKET DYNAMICS 5

Outlook 5

Biopharmaceutical Drugs Fuel Cell Culture Market 5

Market Scenario 6

Industrial vs. Academic 6

Biotechnology Sector - Affected by Collapse of Capital Market 6

Global Market Analysis 6

Market Structure 7

3. TRENDS AND ISSUES 8

US Government's Policies to Boost Cell Culture Market 8

Surging Demand for Cell Culture Products 8

Stem Cells and Vaccines - Key Drivers 8

Growing Acceptance for Hi-Veg Culture Media 8

Fed-Batch Cultures - a Big Hit with Large-Scale Bioprocessors 9

Changing Trend Towards Serum-Free Media 9

Proteomics and Pharmacokinetics to Drive Market Growth 9

Bioresearch and Cell Culture in Protein-Based Drug Development 10

CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture 11

Sluggish Fetal Bovine Serum Market 11

Specialty Media Demand on Rise 11

Emerging Alternatives to Conventional Serum Supplemented Media 12

Growth of Defined Media 12

Regulations Prompt Change in Trends 12

Media Optimization 12

Cell-Line Engineering Vs. Cell Culture Media 12

Other Trends 13

Underlying Threat to Cell Culture Industry 13

Manufacture-on-Demand: Gaining Momentum 13

Move Towards Contract Manufacturing 13

Factors Impacting Growth 14

Business Models Driving the Need for Contract Manufacturing 14

Trends in Contract Manufacturing 14

Target Sectors for Contract Manufacturers 14

4. END-USE ANALYSIS 16

End-Use Applications 16

Cell Therapy 16

Growing by Leaps and Bounds 16

Cell Therapy Applications 17

Key Factors Affecting the Cell Therapy Market 17

Future Trends 17

Related Market Sectors 17

Progenitor Cell Therapy 17

Stem Cell Therapy 18

Other Related Technologies 19

Somatic Cell Nuclear Transfer (SCNT) 19

Tissue Engineering 19

End Use Industries 19

5. CELL/TISSUE CULTURE: PHYSIOLOGICAL OVERVIEW 20

Introduction 20

History 20

Plant Cell and Tissue Culture (PCTC) 24

Cell/Tissue Culture Media, Sera and Reagents 27

Classical Media 27

Specialty Media 28

Serum 28

Fetal Bovine Serum 28

Serum-Free Media 28

Cell Culture Reagents 29

Role of Tissue Culture in the Growth of Cell Types 29

Equipment 29

Storage and Preservation 29

Maintenance 30

Growth Pattern 30

Harvesting 30

Media and Growth Requirements 31

Physiological Parameters 31

Medium Requirements (Often Empirical) 31

Feeding 31

Safety Precautions 31

Methods of Tissue Culture 32

Preparation of Media 32

Growth and Morphology 32

Sub Culturing Adherent Cells 32

Thawing Frozen Cells 32

Freezing Cells 32

Cell Culture Contamination - A Looming Problem 33

Classification 33

Major Cell Culture Contaminants 33

Chemical Contamination 33

Types and Sources of Potential Chemical Contaminants 33

Varied Sources of Chemical Contamination 34

Media and Components 34

Sera 34

Water 35

Storage Vessels 35

Fluorescent Lights 35

Endotoxins 35

Incubators 36

Biological Contamination 36

Varied Sources of Biological Contamination 37

Mycoplasmas 37

Airborne Particles and Aerosols 37

Cross Contamination by Other Cell Cultures 38

Consequences/Problems of Contamination 38

Controlling Cell Culture Contamination 38

Measures Aimed at Reducing Contamination Problems 39

6. REGULATORY ENVIRONMENT 40

7. PRODUCT INNOVATIONS/INTRODUCTIONS 41

StemCells Introduces GS1-R™ 41

Kollodis BioSciences Introduces Cell-Culture Reagents 41

The Automation Partnership Launches Automated Cell-Culture 41

Novartis Receives Approval to Release its New Vaccine 42

Invitrogen Introduces GIBCO® OpTmizer TM T-cell Expansion SFM 42

Novozymes Biopharma Rolls Out CellPrime in Partner ship with

Millipore 42

Invitrogen Launches Dynabeads® SSEA-4 43

Invitrogen Rolls Out KNOCKOUTTM SR XenoFree Media 43

Lonza Develops One-Step Program 43

Millipore Unveils ESGRO CompleteTM PLUS Medium 43

Millipore Introduces Hanging Millicell® Cell Culture Inserts 43

SAFC Biosciences® Launches EX-CELLTM EBx® 44

SAFC Biosciences® Rolls Out EX-Fusion and CHO Library 44

Millipore Launches Epidermal Keratinocyte 3D Medium 44

Invitrogen Rolls Out PD-Direct® Bioprocess Services 45

Millipore Unveils a New Variety of Primary Human Epithelial Cells 45

BD Biosciences Introduces BD Analysis Kit 46

Thermo Fisher Scientific Rolls Out Thermo Clone 46

Lonza Introduces Poietics® Human Natural Killer (NK) Cells 46

Millipore Launches New MillicoatTM Cultureware 47

Millipore Unveils High Content Analysis Kits 47

Millipore Rolls Out FlowCellect™ 47

Invitrogen Introduces GIBCO® Bottles 47

Invitrogen Unveils ST SFM, STEO and STEA Differentiation Kits 48

Thermo Fisher Scientific Launches NuncTM UpCellTM Surface 48

Millipore Releases New Primary Human Epithelial Cell Cultures 48

Millipore Expands Stem Cell Tested Initiative 49

BD Biosciences Debuts BD FACSAria™ II System to Sort Cells 49

Invitrogen Introduces Specific SFM for the Mesenchymal Stem Cells 49

StemCell Launches Cryopreservation Medium Free from Serum 50

Invitrogen Unveils SequalPrep™ System 50

Invitrogen Introduces Animal Source-Free Substrate 50

Invitrogen Introduces GIBCO® FoamAway™ Reagent 50

Genetix Develops New CytoGenetix Reagents and Kits 51

8. PRODUCT INTRODUCTIONS/INNOVATIONS IN THE RECENT PAST -

A PERSPECTIVE BUILDER 52

Thermo Fisher Launches NUNC In Vitro PDL Coated PETG Roller

Bottles 52

Thermo Fisher Scientific Introduces HyClone AdvanceSTEM™ Cell

Culture Product Line 52

Thermo Fisher Scientific Introduces New Medium to Culture PER

.C6 Cell Line 52

Genetix Expands CloneMedia Semi-Solid Media Products 52

Invitrogen Launches STEMPRO® EZPassage™ Tool 53

Sigma-Aldrich Introduces GenomePlex Tissue WGA Kit 53

Thermo Fisher Scientific Introduces Two New Versatile Media

for HEK 293 Cell Line 53

SAFC Biosciences Launches LONG®R3IGF-I in Liquid Form 53

Invitrogen and Novocell Introduce Media for hESC Growth 54

Invitrogen Releases New Culture System 54

Invitrogen Introduces New Line of Engineered Stem Cells 54

BD Biosciences Partners with StemCell Technologies 54

Millipore Launches MEL Cell Lines 55

Irvine Scientific Expands Industrial Cell Culture Product Line 55

Biovest International Introduces Automated Cell Culture Device 55

BD Biosciences Introduces BD FACSDiva™ 6.0 Software 56

Millipore Unveils Nylon Net Steriflip® Filter Unit 56

Lonza Expands Product-Portfolio with Serum Free Media 56

MediCult Unveils Flexible Culture Systems, BlastAssist® and

EmbryoAssist™ 56

Millipore Introduces New Medium for Human Embryonic Stem Cell

Research 57

Invitrogen Launches CytoGenie™ Cytometry Software Tool 57

Novozymes Releases New Cell Culture Components 57

The Automation Partnership Launches Advanced Plating Module 57

Nikon Unveils BioStation CT 58

Corning Launches Innovative Cell Culture Solutions 58

GroPep Introduces New Assay Kit for Cell Culture Business 58

HyClone Introduces HyQ®CDM4MAb™ for Hybridoma Cell Lines 58

INTEGRA Biosciences Adds Alarm Interface to CELLROLL and

CELLSPIN Systems 59

Nikon Launches New Imaging and Tracking Systems for Cell Culture 59

Genetix Develops Cell Dispenser 59

SAFC Biosciences Introduces LONGTMR3IGF-I for Industrial Cell

Culture 59

Biocrystal Presents Opticell 59

TAP Unveils CompacT SelecT™ 60

New Brunswick Scientific Augments New Products to Cell Culture

Systems 60

Cell Culture Technologies Develops Fortified Production Media 60

9. RECENT INDUSTRY ACTIVITY 61

Akron Biotechnology Merges with AppliChem 61

ChanTest Takes Over Applied Cell Sciences 61

Millipore to Takeover Guava Technologies 61

Millipore Acquires EpiTagTM Technology from Epitome Biosystems 62

MediCult's BlastAssist® Culture Media Obtains FDA Approval 62

Capsant Signs Commercialization Agreement with VistaGen 62

Millipore Inks Distribution Agreement with Solabia 63

Helix BioMedix Signs Production and Supply Agreement with

Peptisyntha 63

BD Biosciences to Establish New Production Facility 63

Lonza Group Takes Over amaxa 64

Millipore and Bayer Healthcare Sign Agreement 64

Applied Biosystems and Invitrogen Merge 64

SAFC BiosciencesTM and Celltrion Enter into Agreement 64

Tata Chemicals to Acquire Stake in Joil 65

Sartorius Stedim Biotech Acquires Wave Biotech 65

Sigma-Aldrich and AlphaGenix Sign Distribution Agreement 65

Induce Biologics and Therapure Biopharma Enter into Collaboration 65

International Stem Cell and Millipore Sign Distribution Agreement 65

Lonza Signs Agreement with Crucell 66

Eden Biodesign and Human Genome Sciences Sign Agreement 66

Becton, Dickinson to Establish New Production Facility 66

MedCell Bioscience Merges with NovaThera 66

Covidien UK Holding Takes Over Tissue Science Laboratories 67

Invitrogen Establishes Dedicated Business Unit for Cell Therapy 67

Invitrogen Signs Deal to Acquire CellzDirect 67

Invitrogen Renews Agreement with Luminex Corporation 67

BioTime Establishes Tissue Culture Facility 68

International Stem Cell Signs Agreement with ATCC 68

Millipore Signs Agreement with Solabia to Distribute Animal-

Free Hydrolysates 68

Affymetrix Acquires USB Corporation 69

SAFC to Expand Production Capacity of Viral Product 69

Lonza Signs Partnership Agreement with Sanofi to Produce Cell

Culture Vaccine 69

10. STRATEGIC CORPORATE ACTIVITY IN THE RECENT PAST -

A PERSPECTIVE BUILDER 70

SAFC to Increase Fermentation Capabilities of High-Potency API 70

Biogen Offers Contract to Jacobs Engineering Group 70

New Brunswick Scientific Merges with Eppendorf Group 70

Vitrolife Extends Agreement with Cellartis 70

Sigma-Aldrich Inks Distribution Agreement with CellPath 70

Lonza Acquires two Subsidiaries of Cambrex Bio-Businesses 71

Vikdas to Build Biotechnological Laboratory 71

Novartis to Invest in a New Cell Culture Plant in Singapore 71

Invitrogen Signs Agreement with Biocon 71

Lonza and Bio*One form Joint Venture for Mammalian Cell

Culture Plant 71

Thermo Fisher to Extend Manufacturing Operations 72

BD Biosciences Announces Treyburn Expansion Plans 72

BD Biosciences Collaborates with Roche to Advance Cell Signal

Transduction Study 72

Invitrogen and RXi Pharmaceuticals Enter into Collaboration 73

Millipore Forms a Strategic Alliance with Novozymes 73

Thermo Fisher Takes Over OptiCell Product Line 73

Invitrogen Collaborates with Cytori for Research on Adipose

Stem Cell 73

Thermo Fisher Partners with Cellular Engineering for Stem Cell

Research 74

VWR Signs Agreement to Distribute Biovest's Cell Culture Device 74

Genentech Constructs New Cell Culture Plant 74

Invitrogen Signs Deal with Wave Biotech to Offer Media-Filled

Disposable Bioreactors 74

MediCult Purchases Humagen Fertility 74

Millipore Acquires Serologicals 75

ReNeuron Inks Collaboration Agreement with CellSeed 75

Trans Valley Launches Tissue Cultured Variety of Mushrooms 75

HiMedia Laboratories Forges Distribution Deal with VWR

International 75

Teva Signs Collaboration Agreement with Protalix Biotherapeutics 75

SAFC-Biosciences Forms to Support Sigma-Aldrich 76

Invitrogen and Cellartis to Co-develop hESC Reporter Lines 76

CELLCA and Rentschler Join Forces for Unique High-Level

Expression System 76

ArcDia Partners with Chip-Man Technologies 76

Chugai Pharmaceutical Receives License for Cell Line from

Cambrex Bio Science Walkersville, Inc. 76

Chemicon Inks Distribution Agreement with CELLnTEC 77

Chemicon Signs an Agreement with ReNeuron 77

Chemicon to Market Stem Cell Products of ASCC 77

SCS and Chemicon Introduce ESGRO Complete™ Product Range 77

Serologicals Acquires Cytomyx Ltd 78

Millipore to Take Over Serologicals 78

CAT Opts SelectT™ for Higher Cell Culture Yields 78

11. FOCUS ON SELECT MAJOR PLAYERS 79

Affymetrix, Inc. (USA) 79

AMRESCO, Inc. (USA) 79

BD Biosciences (USA) 79

Cell Culture Technologies, LLC (Switzerland) 80

Cell Essentials, Inc. (USA) 80

Irvine Scientific (USA) 80

Life Technologies Corporation (USA) 80

Lonza Biologics Plc (UK) 81

Mediatech, Inc. (USA) 81

Millipore Corporation (USA) 81

Medi-Cult A/S (Denmark) 81

MP Biomedicals (USA) 82

PerBio Science AB (Sweden) 82

PromoCell GmbH (Germany) 82

Sera Laboratories International (UK) 82

Sigma-Aldrich Corporation (USA) 83

SAFC Biosciences (USA) 83

Vitrolife AB (Sweden) 83

12. GLOBAL MARKET PERSPECTIVE 84

Table 1: World Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Geographic Region - USA,

Canada, Japan, Europe, Asia-Pacific (excluding Japan) and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 84

Table 2: World Historic Review for Cell/Tissue Culture

Supplies by Geographic Region - USA, Canada, Japan, Europe,

Asia-Pacific (excluding Japan) and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 85

Table 3: World 11-Year Perspective for Cell/Tissue Culture

Supplies by Geographic Region - Percentage Breakdown of Dollar

Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding

Japan) & Latin America Markets for Years 2005, 2010 & 2015

(includes corresponding Graph/Chart) 86

Cell/Tissue Culture Supplies Market by Product Segment 87

Table 4: World Recent Past, Current & Future Analysis for

Media Cell/Tissue Culture Supplies by Geographic Region - USA,

Canada, Japan, Europe, Asia-Pacific (excluding Japan) and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 87

Table 5: World Historic Review for Media Cell/Tissue Culture

Supplies by Geographic Region - USA, Canada, Japan, Europe,

Asia-Pacific (excluding Japan) and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 88

Table 6: World 11-Year Perspective for Media Cell/Tissue

Culture Supplies by Geographic Region - Percentage Breakdown

of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific

(excluding Japan) & Latin America Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 89

Table 7: World Recent Past, Current & Future Analysis for Sera

Cell/Tissue Culture Supplies by Geographic Region - USA,

Canada, Japan, Europe, Asia-Pacific (excluding Japan) and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 90

Table 8: World Historic Review for Sera Cell/Tissue Culture

Supplies by Geographic Region - USA, Canada, Japan, Europe,

Asia-Pacific (excluding Japan) and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 91

Table 9: World 11-Year Perspective for Sera Cell/Tissue

Culture Supplies by Geographic Region - Percentage Breakdown

of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific

(excluding Japan) & Latin America Markets for Years2005, 2010 &

2015 (includes corresponding Graph/Chart) 92

Table 10: World Recent Past, Current & Future Analysis for

Reagent Cell/Tissue Culture Supplies by Geographic Region -

USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 93

Table 11: World Historic Review for Reagent Cell/Tissue

Culture Supplies by Geographic Region - USA, Canada, Japan,

Europe, Asia-Pacific (excluding Japan) and Latin American

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 94

Table 12: World 11-Year Perspective for Reagent Cell/ Tissue

Culture Supplies by Geographic Region - Percentage Breakdown

of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific

(excluding Japan) & Latin America Markets for Years2005, 2010 &

2015 (includes corresponding Graph/Chart) 95

13. THE UNITED STATES 96

A.Market Analysis 96

Current & Future Analysis 96

Cell & Tissue Culture Market 96

A Brief Insight 96

Market Trends 97

Trend Towards Serum-Free Media 97

Liquid and Powdered Media Account for Major Share 97

Table 13: Leading Players in the US Cell Culture Media

Market (2008): Percentage Breakdown of Sales for -

Sigma-Aldrich, Hyclone, Lonza Biologics, and Others

(includes corresponding Graph/Chart) 97

Fetal Bovine Serum - On A Decline 98

Rise in Cell Culture Equipment Demand Leads to Innovation 98

Market for Stem Cell Research 98

End-Use Analysis 99

Table 14: US Market for Cell Culture Reagents by End Use -

Academic, Industrial, and Non-Academic (2008) (includes

corresponding Graph/Chart) 99

Factors Influencing the Market for Tissue and Cell Culture

Media 99

Regulatory Controls 99

Guidelines Governing Use of Cell/Tissue Culture Reagents 100

MSDS and Hazardous Information 100

Toxic Substances Control Act 100

B.Market Analytics 101

Table 15: US Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 101

Table 16: US Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 102

Table 17: US 11-Year Perspective for Cell/Tissue Culture

Supplies by Product Segment - Percentage Breakdown of Dollar

Sales for Media, Sera, and Reagents Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 103

14. CANADA 104

A.Market Analysis 104

Current & Future Analysis 104

Biotechnology Industry 104

B.Market Analytics 105

Table 18: Canadian Recent Past, Current & Future Analysis

for Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 105

Table 19: Canadian Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 106

Table 20: Canadian 11-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 106

15. JAPAN 107

A.Market Analysis 107

Current & Future Analysis 107

B.Market Analytics 107

Table 21: Japanese Recent Past, Current & Future Analysis

for Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 107

Table 22: Japanese Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 108

Table 23: Japanese 11-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 108

16. EUROPE 109

A.Market Analysis 109

Current & Future Analysis 109

Market Overview 109

B.Market Analytics 110

Table 24: European Recent Past, Current & Future Analysis

for Cell/Tissue Culture Supplies by Geographic Region -

France, Germany, UK, Italy & Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 110

Table 25: European Historic Review for Cell/Tissue Culture

Supplies by Geographic Region - France, Germany, UK, Italy

and Rest of Europe Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2000 through

2006 (includes corresponding Graph/Chart) 111

Table 26: European Recent Past, Current & Future Analysis

for Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 112

Table 27: European Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 113

Table 28: European 11-Year Perspective for Cell/Tissue

Culture Supplies by Geographic Region - Percentage Breakdown

of Dollar Sales for France, Germany, UK, Italy & Rest of

Europe Markets for Years2005, 2010 & 2015 (includes

corresponding Graph/Chart) 114

Table 29: European 11-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 115

16a. FRANCE 116

Market Analysis 116

Current & Future Analysis 116

Table 30: French Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 116

Table 31: French Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 117

Table 32: French 11-Year Perspective for Cell/Tissue Culture

Supplies by Product Segment - Percentage Breakdown of Dollar

Sales for Media, Sera, and Reagents Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 117

16b. GERMANY 118

A.Market Analysis 118

Current & Future Analysis 118

Biotech Research Scenario 118

Table 33: German Biotech Market (2009): Percentage

Breakdown by Application Area - Environment, Human Health

Care, Chemical industry, Food, Agriculture, Energy, and

Others (includes corresponding Graph/Chart) 119

B.Market Analytics 119

Table 34: German Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 119

Table 35: German Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 120

Table 36: German 11-Year Perspective for Cell/Tissue Culture

Supplies by Product Segment - Percentage Breakdown of Dollar

Sales for Media, Sera, and Reagents Markets for Years2005,

2010 & 2015 (includes corresponding Graph/Chart) 120

16c. ITALY 121

Market Analysis 121

Current & Future Analysis 121

Table 37: Italian Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 121

Table 38: Italian Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 122

Table 39: Italian 11-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 122

16d. THE UNITED KINGDOM 123

A.Market Analysis 123

Current & Future Analysis 123

Biotechnology Industry - A Brief Insight 123

Regulatory Issues 124

HFE Act Guidelines 124

The Ethical Issues 124

B.Market Analytics 125

Table 40: UK Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 125

Table 41: UK Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2011 through 2015 (includes

corresponding Graph/Chart) (includes corresponding

Graph/Chart) 126

Table 42: UK 11-Year Perspective for Cell/Tissue Culture

Supplies by Product Segment - Percentage Breakdown of Dollar

Sales for Media, Sera, and Reagents Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 126

16e. REST OF EUROPE 127

A.Market Analysis 127

Current & Future Analysis 127

Scenario in other European Countries 127

B.Market Analytics 128

Table 43: Rest of Europe Recent Past, Current & Future

Analysis for Cell/Tissue Culture Supplies by Product Segment -

Media, Sera, and Reagents Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 128

Table 44: Rest of Europe Historic Review for Cell/Tissue

Culture Supplies by Product Segment - Media, Sera, and

Reagents Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 129

Table 45: Rest of Europe 11-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera and Reagent Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 130

17. ASIA-PACIFIC 131

A.Market Analysis 131

Current & Future Analysis 131

Rise of Cell Culture in Asia 131

India 131

Cell Culture Market Constituents 131

China 132

Taiwan 132

Australia 132

B.Market Analytics 133

Table 46: Asia-Pacific Recent Past, Current & Future

Analysis for Cell/Tissue Culture Supplies by Product Segment -

Media, Sera, and Reagents Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 133

Table 47: Asia-Pacific Historic Review for Cell/Tissue

Culture Supplies by Product Segment - Media, Sera, and

Reagents Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 134

Table 48: Asia-Pacific 11-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera and Reagent Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 135

18. LATIN AMERICA 136

A.Market Analysis 136

Current & Future Analysis 136

Brazilian Biotech Industry 136

B.Market Analytics 137

Table 49: Latin American Recent Past, Current & Future

Analysis for Cell/Tissue Culture Supplies by Product Segment -

Media, Sera, and Reagents Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 137

Table 50: Latin American Historic Review for Cell/Tissue

Culture Supplies by Product Segment - Media, Sera, and

Reagents Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 138

Table 51: Latin American 11-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera and Reagent Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 139

COMPETITION

Total Companies Profiled: 131 (including Divisions/Subsidiaries - 151)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 89

Canada 4

Japan 2

Europe 45

France 2

Germany 10

The United Kingdom 19

Spain 1

Rest of Europe 13

Asia-Pacific (Excluding Japan) 7

Latin America 1

Middle East 3

------------------------------------------

To order this report:

Biotechnology Industry: Global Cell/Tissue Culture Supplies Industry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker